Update of the EORTC Health-related Quality of Life Modules for Bladder Cancer: Phase 1-2 of the Development Process.

Saved in:
Bibliographic Details
Title: Update of the EORTC Health-related Quality of Life Modules for Bladder Cancer: Phase 1-2 of the Development Process.
Authors: Rammant E; End-of-Life Care Research Group, Vrije Universiteit Brussel (VUB) & Ghent University, Ghent, Belgium. Electronic address: elke.rammant@ugent.be., Fox L; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK., De Padova S; Psycho-Oncology Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori,' Meldola, Italy., Liedberg F; Istitution of Translational Medicine, Lund University, Malmö, Sweden., Wintner LM; Department of Psychiatry, Psychotherapy, Psychosomatics and Medical Psychology, University Hospital of Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria., Holzner B; Department of Psychiatry, Psychotherapy, Psychosomatics and Medical Psychology, University Hospital of Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria., Aaronson NK; Division of Psychosocial Research & Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Beyer K; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK., Bex A; The Royal Free London NHS Foundation Trust, London, UK; UCL Division of Surgery and Interventional Science, London, UK; Department of Urology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Čapoun O; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic., Catto JWF; Academic Urology Unit, Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK., Chaloner R; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK., Costin M; Fight Bladder Cancer, Oxfordshire, UK., Decaestecker K; Department of Urology Maria Middelares General Hospital, Ghent, Belgium., Enting D; Guy's & St. Thomas' NHS Foundation Trust, London, UK., Fonteyne V; Department of Human Structure and Repair, Ghent University, Ghent, Belgium., Hendricksen K; Department of Surgical Oncology (Urology), Netherlands Cancer Institute, Amsterdam, the Netherlands., Kachel T; Department of Psychiatry, Psychotherapy, Psychosomatics and Medical Psychology, University Hospital of Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria., Kassianos A; Department of Nursing, Cyprus University of Technology, & Cancer Research and Innovation Centre (CARIC), Limassol, Cyprus., Lewis R; Clinical Trials and Statistics Unit (ICR-CTSU), The Institute of Cancer Research, London, UK., Makaroff L; Fight Bladder Cancer, Chinnor, UK; World Bladder Cancer Patient Coalition, Brussels, Belgium., Morcom E; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK., Neuzillet Y; Department of Urology, Foch Hospital, University of Versailles-Saint-Quentin-en-Yvelines, Suresnes, France., O'Brien T; Department of Urology, Guy's and St. Thomas' National Health Service Foundation Trust, London, UK., Pappot H; Department of Oncology, Copenhagen University Hospital, Copenhagen Ø, Denmark., Philipps L; Clinical Trials and Statistics Unit (ICR-CTSU), The Institute of Cancer Research, London, UK., Richters A; Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands., Ripping DM; Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands., Rouanne M; Department of Urology, Foch Hospital, University of Versailles-Saint-Quentin-en-Yvelines, Suresnes, France., Rudman S; Guy's & St. Thomas' NHS Foundation Trust, London, UK., Shrestha S; School of Pharmacy, Monash University, Malaysia., Soukup V; Department of Urology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic., Spaas M; Department of Human Structure and Repair, Ghent University, Ghent, Belgium., Sztankay M; Department of Psychiatry, Psychotherapy, Psychosomatics and Medical Psychology, University Hospital of Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria., Thomas C; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK., van Leeuwen M; Division of Psychosocial Research & Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Van Hemelrijck M; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.
Corporate Authors: EORTC Quality of Life Group
Source: European urology oncology [Eur Urol Oncol] 2026 May 26. Date of Electronic Publication: 2026 May 26.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101724904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2588-9311 (Electronic) Linking ISSN: 25889311 NLM ISO Abbreviation: Eur Urol Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2588-9311
DOI:10.1016/j.euo.2026.04.016